DOI: 10.36347/sjams.2018.v06i10.044

Pages: 3910-3912

Neonatal Graves’ disease is a rare disorder seen in 1% of the offspring of mothers with either established or cured Graves’ disease (GD). It results from the transplacental transfer of thyroid stimulating immunoglobulins (TSIs) from mother to fetus, in women with GD. A higher TSIs antibody in maternal serum makes hyperthyroidism more likely in the fetus or newborn. In spite of its rarity, its serious nature and its association with multisystem abnormalities justifies careful clinical screening and management. We report a term neonate with neonatal Graves` disease secondary to maternal Graves’ disease. The patient was treated accordingly with a good response.